Mailman's ICAP program is well-known for its efforts in fighting HIV, malaria, and TB around the world, but they're also busy in the fight against COVID-19 in nearby Harlem and Bronx neighborhoods.
A systematic screening program designed for athletes testing positive for COVID-19 has detected a low incidence of inflammatory heart disease, so far returning professional athletes safely to sport.
A 15-minute COVID-19 test that can be used at home to identify infectious people is under development in David Ho’s laboratory and has received support from the NYC Economic Development Corporation.
The first CUIMC Grand Rounds, launched by the four deans of Columbia University Irving Medical Center schools, was presented by David Ho, MD, on new variants of the coronavirus.
People who took statins to lower cholesterol were about 50% less likely to die if hospitalized for COVID-19, a retrospective study by Columbia University and NewYork-Presbyterian physicians has found.
Spread of a new SARS-CoV-2 variant in the New York City region that shares worrisome similarities with other recent variants has been identified by scientists at Columbia University.
Since the beginning of the pandemic, more than 120 million people in the United States may have been infected by SARS-CoV-2, according to researchers at the Mailman School of Public Health.
Pregnant women face greater risks to their health from COVID-19 than the general population and should be offered a vaccine if eligible, say experts at Columbia and NewYork-Presbyterian.